Rhabdomyosarcoma in Children: Early Warning Signs

A child’s body gives indications that something is wrong; long before a diagnosis is possible. Parents are always noticing these things, and – most of the time – they don’t mean anything serious. Rhabdomyosarcoma in children is a condition where that sensible parents wish to hold off and watch carefully results in the biggest delays in getting to a diagnosis, and beginning treatment. 

This isn’t a cancer which makes itself known clearly or in a dramatic way. Rhabdomyosarcoma develops in places which aren’t expected, causes symptoms which are the same as ordinary childhood illnesses, and often is at a worrying level before any doctor links what is happening to a soft tissue cancer. Understanding which signs really need looking into makes a difference to children, and to the families who help them. 

Why Children Account for Most Diagnosed Cases 

Soft tissue sarcomas are unusual in all ages, but rhabdomyosarcoma cancer is the most frequent soft tissue cancer found in people younger than fifteen. It makes up around a half of all childhood soft tissue sarcomas in the world. The illness is at its worst in two age groups: small children of two to six years old, and teenagers between fourteen and eighteen. 

The way this tumour starts in cells explains why children are affected more than others. Rhabdomyosarcoma comes from primitive mesenchymal cells – the same early cells which make skeletal muscle while a baby is growing, and in the early months after birth. When these cells turn into cancer during periods of fast growth, the resulting tumour is able to develop in almost any part of the body. 

How Subtype Determines Everything That Follows 

Rhabdomyosarcoma types do not act the same in children, and the type found by a biopsy affects every next choice about how strong the treatment should be, the way any surgery is done, and how patients are checked after treatment. Giving the same treatment to all types gives clearly worse results than planning treatment depending on the type, and that’s why knowing the type of the disease is so important at all stages of finding out what is wrong. 

• Embryonal rhabdomyosarcoma is the most common type in children, and accounts for most childhood cases. It usually shows in the head, neck and urinary/reproductive systems, and reacts well to usual chemotherapy. 
• Alveolar rhabdomyosarcoma is different, showing more often in the body and arms/legs, having changes in chromosomes which cause it to act more aggressively and need stronger treatment plans from the time of diagnosis. 

Early Rhabdomyosarcoma Symptoms Parents Should Not Dismiss 

Rhabdomyosarcoma symptoms in children are very much dependent on where in the body the cancer is, and that’s exactly what makes them so hard to recognise unless someone knows what to look for. Most parents first notice a lump or swelling which has no explanation. The difficulty is telling a soft tissue cancer apart from the much more common bumps and swollen glands which are part of what children normally experience. The following should have quick review by a specialist: 

• A gradual swelling of one eye towards the front, developing over days to weeks with no clear injury or infection 
• Blood in urine in a child where no urine infection has been shown by tests in a laboratory 
• A painless, solid swelling in the neck, arm or leg, or stomach which doesn’t get smaller over two or three weeks 
• Blocked nose, constant bleeding from the nose, or swelling on one side of the face which doesn’t get better with antibiotics 

Rhabdomyosarcoma symptoms are very similar to ordinary childhood illnesses, and that similarity is what makes early recognition really difficult. The most important thing is how long a symptom or swelling lasts. Any symptom or swelling which doesn’t get better in the time expected for a harmless illness needs to be looked at again, using a wider range of tests, rather than being watched. 

Tumour Locations and the Signs They Produce 

The places in the body where rhabdomyosarcoma in children develops - follow certain predictable patterns. Around forty per cent of childhood cases are in the head and neck; eye socket tumours are one of the most usual of these. The urinary and reproductive systems account for about twenty per cent of cases, and bladder tumours are seen in younger boys – those under six – who have problems with urination, or blood in their urine. 

Tumours in the arms or legs are more typical in teenagers, and these need careful checking of the nearby lymph nodes to find out whether the cancer has spread to them. Centres such, manage these complicated childhood cases by means of complete cancer programmes that combine children’s surgery, radiotherapy, and chemotherapy in a single, well-organised system which is adjusted to the child’s particular tumour site and type. 

Diagnostic Steps That Cannot Be Abbreviated 

Diagnosis begins with MRI, which is the best form of scan for looking at a possible soft tissue growth in a child, as it shows the tissues in more detail than CT scans can, for assessing the disease locally. CT scans of the chest, stomach, and pelvis are then done to check for the cancer having spread further afield. A bone marrow biopsy finishes off staging in the higher-risk cases, where cancer in the system at the time of diagnosis has a real chance of occurring. 

A tissue biopsy to confirm rhabdomyosarcoma must include molecular examination. If the PAX-FOXO1 gene is fused – which is linked to alveolar rhabdomyosarcoma – patients are put into risk groups that directly affect how intense the chemotherapy is, and radiation is planned. Starting treatment without this molecular information means making important clinical choices without the information needed to make the intensity of treatment match the actual behaviour of the individual tumour. 

Treatment Shaped by Stage, Site, and Age 

Embryonal rhabdomyosarcoma with completely removed, contained disease has the best treatment results in all the published children’s cancer trials. VAC chemotherapy – vincristine, actinomycin-D, and cyclophosphamide – is the usual standard systemic treatment for most children. Surgery controls the disease locally where complete removal is possible without causing unacceptable loss of function in a growing child, whose development must also be taken into account in the treatment planning. 

Radiotherapy is used when surgery cannot get clear edges, or when the site of the tumour makes complete removal impossible without great harm to the patient. Rhabdomyosarcoma in adults, treated using treatments developed for children, usually needs dose adjustments to reflect different organ tolerances. Pleomorphic rhabdomyosarcoma – though rarely seen in children – requires different methods, given its different cell biology and less consistent response to the usual children’s chemotherapy mixtures. 

Monitoring Children Closely After Treatment Ends 

Organised check scans continue at set times for at least five years after treatment is over, for all types. Late recurrences outside the usual two-year check period – though not common – are recorded in published children’s cancer reports, and are not just theoretical possibilities which can safely be ignored. Children treated for rhabdomyosarcoma in adult-linked types like alveolar structure require especially careful follow-up, as they have a higher basic risk of the cancer coming back. 

Parents are still vital in watching for things after treatment. Any new swelling, unexplained pain in the bones, change in breathing, or nervous system symptom which appears during the check period should be reported to the treatment team immediately, rather than watched at home. Rhabdomyosarcoma cancer which comes back after first treatment has far fewer options for being saved, which makes sticking to check-ups throughout the monitoring period directly relevant to the long-term results for every child treated.